Evidence map›Paper›PMID 42453414›Full record

ArticleActa pharmaceutica Sinica. B2026

FlowDock: A unified flow-based framework for flexible protein-ligand docking and binding affinity prediction.

Jing Li, Ruiqiang Lu, Yi Tan, Pengyu Liang, Bo Liu, Shukai Gu, Huanxiang Liu, Xiaojun Yao

Abstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jing LiCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
Ruiqiang LuCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
Yi TanCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
Pengyu LiangCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
Bo LiuCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
Shukai GuCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
Huanxiang LiuCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
Xiaojun YaoCentre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate prediction of protein-ligand complexes and binding affinity is critical for hit identification and optimization for structure-based drug design. Traditional docking simulates binding processes with searching algorithms guided by energy-scoring functions, which are quite computationally expensive and time-intensive. In contrast, deep learning approaches offer a cost-effective alternative, yet often generate conformations with limited physicochemical validity and fail to account for protein flexibility. To address these pitfalls, we propose FlowDock, a multitask framework enhanced by Bayesian Flow Networks. FlowDock simultaneously generates accurate protein-ligand complex structures and predicts binding affinity while incorporating protein conformational flexibility. By leveraging multimodal intramolecular representations with a deep equivariant generative model, our method iteratively refines complex in latent space, ensuring rapid and stable generation. Benchmark evaluations demonstrate that FlowDock achieves state-of-the-art performance in binding pose prediction, especially physical plausibility, and virtual screening capability, alongside reliable binding affinity predictions. By providing deeper molecular insights into dynamic protein-ligand interactions, FlowDock represents a robust tool for accelerating the rational development of therapeutics.

Indexed as

Bayesian flow networksBinding affinity predictionDeep equivariant generative modelsLatent space optimizationMachine learning in drug discoveryProtein–ligand dockingStructure-based drug design

Identifiers

PMID42453414
PMCPMC13366307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.